Articles

Pfizer is buying its way back into the obesity-drug game after fighting off a rival bid from Novo Nordisk to buy Metsera, with more money and help from the Trump administration.

Questions about Microstrategy’s business model, copycat products and a stalling in the bitcoin price might have contributed to the decline in MSTR’s mNAV.

The key question, beyond the logistics of actually introducing such a product, is how much of a benefit in terms of affordability would it provide.

BNP Paribas’s Stefan Slowinski warned about Meta’s unchecked AI spending. Now he thinks the stock’s recent selloff is just the beginning.

Some of the long-term supportive tailwinds are shifting, according to MRB

“Once the check clears, the buyer will send a trailer to pick up the car.”

Goldman Sachs note thinks there’s still plenty of scope for the current bonanza in AI stocks to continue but investors should be wary of the risks.

Shares of Taiwan Semi are climbing as tech stock rise and customer Nvidia is apparently demanding lots more of its wafers.

“I have a mortgage balance of $600,000 on a $1.7 million house.”

DiCaprio put the “rare and special” waterfront dwelling on the market in July for $23 million.

Redick’s lavish New York penthouse has four bedrooms and 4.5 bathrooms and is perched atop a seven-story converted warehouse.

U.S. stock futures gained Sunday, despite coming off the worst week for tech stocks since April, as investors clung to indications that a deal may be in the works to end the government shutdown.